HKEX Insider Activity β 2026-08-25
ππ° HKEX DI Report β 2026-08-25
π’ ACCUMULATING β 1276 Hengrui Pharmaceuticals (H) β GIC, 15.70% (increased by 1.41pp from prior filing), bought 3,658,600 shares @ HKD 50.57 for HKD 185.0M total
Read: A sovereign wealth fund adding to a >15% stake in China's leading biopharma is a strong institutional confidence signal.
π’ ACCUMULATING β 3759 Pharmaron Beijing (H) β JPMorgan, 8.60% (increased by 1.12pp), bought 4,036,431 shares @ HKD 34.04 for HKD 137.4M total
Read: A meaningful HK$137M top-up shows JPMorgan leaning further into the China CRO name.
π΄ DISTRIBUTING β 1783 Envision Greenwise Holdings β Chun Yip International Investment Limited, 36.47% (decreased by 1.49pp), disposed of 117,924,000 shares @ HKD 4.66 for HKD 549.5M total
Read: The controlling shareholder offloaded a HK$550M block (unspecified transaction type) while still holding over a third of the company β worth watching for further reductions.
π NEW ENTRY β 279 Arta TechFin β AspireEdge Limited, first crossed the 5% threshold at 29.16%, acquired 406,949,272 shares @ HKD 0.49 for HKD 199.4M total
Read: AspireEdge shows up as a fresh near-30% holder right out of the gate β large enough to raise control questions.
π NEW ENTRY β 1566 CA Cultural Technology Group β Kenichi Yanase, first crossed the 5% threshold at 203.25%, position worth HKD 255.0M @ HKD 0.1772/share
Read: An interest above 100% points to heavy convertible/derivative exposure rather than a plain share buy β a structural filing, not a simple bull signal.
π NEW ENTRY β 552 China Communications Services (H) β BlackRock, 5.12% (increased by 0.13pp), re-crossed 5% after a related-entity reallocation (reason 1004)
Read: The move back above 5% is marginal, so this reads as bookkeeping across BlackRock's vehicles rather than fresh conviction buying.
π NEW ENTRY β 3323 China National Building Material (H) β BlackRock, 5.92% (increased by 1.05pp), re-crossed 5% via related-entity reallocation, 39,024,229 shares involved
Read: A real step-up in aggregate exposure (+1.05pp) makes this look like genuine accumulation dressed as a 1004 filing.
π NEW ENTRY β 3618 Chongqing Rural Commercial Bank (H) β JPMorgan, 5.00% (increased by 0.09pp), bought 2,143,774 shares @ HKD 6.44 for HKD 13.8M total
Read: JPMorgan's stake is sitting right on the 5% wire β a borderline re-entry worth watching for direction.
π NEW ENTRY β 1766 CRRC (H) β BlackRock, 5.34% (increased by 0.48pp), re-crossed 5% via related-entity reallocation, 20,889,583 shares involved
Read: A moderate net add pushed BlackRock's aggregate CRRC position back above the notifiable line.
π NEW ENTRY β 2442 Easy Smart Group Holdings β HELLOAI Global Tech Ltd / Terminus Consumer Limited / Lingli Meng (single ownership chain), first crossed 5% at 25.00% each, 102,000,000 shares
Read: A concentrated 25% block moved into a new HELLOAIβTerminusβMeng control chain β a fresh strategic stake worth tracking for a possible offer.
π NEW ENTRY β 2208 Goldwind Science & Technology (H) β Bank of America, 5.06% (increased by 0.18pp), bought 1,354,800 shares @ HKD 10.75 for HKD 14.6M total
Read: A small, mostly technical crossing just above the 5% threshold.
π NEW ENTRY β 1801 Innovent Biologics β JPMorgan, 5.06% (increased by 0.13pp), bought 2,355,489 shares @ HKD 102.24 for HKD 240.8M total
Read: A sizeable HK$241M buy pushed JPMorgan just past 5% in one of China's top biotech names.
π NEW ENTRY β 3696 InSilico Medicine β JPMorgan, 5.56% (increased by 0.73pp), bought 4,294,500 shares @ HKD 43.42 for HKD 186.5M total
Read: A near-HK$187M fresh position marks notable institutional entry into the AI-drug-discovery name.
π’ BUYBACK β 3636 Yunnan Jinxun Resources (H) β issuer repurchase (reflected via JPMorgan's stake), 6.52% (decreased by 1.48pp), 625,900 shares @ HKD 18.12 for HKD 11.3M total retired
Read: Passive holders' percentages rose from share-count shrinkage, signaling the issuer is actively buying back stock.
βοΈ OPTION/CONVERSION β 881 Zhongsheng Group Holdings β Jardine Matheson / Jardine Strategic / JMH Investments / JSH Investment Holdings (Jardine group chain), 12.97% (decreased by 1.34pp), subscribed 32,000,000 new shares @ HKD 4.36 for HKD 139.5M total each
Read: Jardine subscribed for new shares yet its stake still fell, meaning the broader placement diluted faster than the group's own buy-in β a structural filing, not a sell signal.
No redactions applied.
Published via wiis. Originals are encrypted at rest; this page reflects the redacted version. report abuse.
Discussion
No comments yet.